Director, Clinical Operations Severe Asthma

About Generate:Biomedicines

Generate:Biomedicines is a new kind of therapeutics company existing at the intersection of machine learning biological engineering and medicine pioneering Generative Biology to create breakthrough medicines where novel therapeutics are computationally generated instead of being discovered. The Company has built a machine learning-powered biomedicines platform with the potential to generate new drugs across a wide range of biologic modalities. This platform represents a potentially fundamental shift in what is possible in the field of biotherapeutic development.

We pursue this audacious vision because we believe in the unique and revolutionary power of generative biology to radically transform the lives of billions with an outsized opportunity for patients in need. We are seeking collaborative relentless problem solvers that share our passion for impact to join us!

Generate:Biomedicines was founded in 2018 by Flagship Pioneering and has received nearly $700 millionin funding providing the resources to rapidly scale the organization. The Company has offices in Somerville and Andover Massachusetts with 300 employees.

The Role:

As we expand our late-stage development organization we are seeking a Director Clinical Operations Severe Asthma to provide strategic and operational leadership for global Phase 3 development. This role will serve as the operational leader across one or more complex late-stage asthma studies with full accountability for study strategy execution quality budget and delivery.

In addition to program leadership this role includes direct line management of Clinical Operations professionals with responsibility for hiring developing coaching and building high-performing teams. The Director will play a key role in shaping operational strategy advancing functional excellence and strengthening Generates late-stage development capabilities.

Heres how you will contribute:

Program Leadership

Provide strategic oversight and end-to-end operational leadership for global Phase 3 asthma studies and related development activities.

Translate program strategy into comprehensive executable operational plans aligned with regulatory scientific and corporate objectives.

Accountable for study timelines budgets resource allocation quality metrics and overall delivery.

Lead scenario planning risk forecasting and mitigation strategies at the program level.

Partner with Clinical Development leadership to inform portfolio-level planning and decision-making.

People Leadership & Organizational Development

Directly manage and develop Clinical Operations staff (e.g. Clinical Trial Leads and/or Clinical Trial Managers).

Recruit hire onboard and retain top talent to support late-stage clinical development.

Set performance expectations conduct evaluations provide coaching and support career development.

Build a culture of accountability collaboration and operational excellence.

Cross-Functional Collaboration

Lead multidisciplinary study teams across Clinical Operations Data Management Biostatistics Safety Regulatory Medical Quality and CMC.

Act as a primary point of accountability across internal stakeholders CRO partners and external vendors.

Enable effective decision-making timely escalation and transparent communication across teams.

Operational Excellence & Risk Management

Oversee global study startup site strategy enrollment execution monitoring approaches and patient engagement initiatives.

Ensure compliance with ICH-GCP global regulatory requirements and internal SOPs.

Provide oversight of study budgets vendor performance and quality metrics.

Establish performance metrics and drive continuous improvement across external partnerships.

Lead inspection readiness strategy and support regulatory inspections.

Drive proactive issue identification risk management and CAPA oversight.

Functional Leadership & Process Improvement

Contribute to Clinical Operations strategy infrastructure development and process optimization.

Champion innovation in trial execution including digital tools decentralized approaches and patient-focused strategies.

Share best practices and help define standards across the clinical operations organization.

The Ideal Candidate will have:

1215 years of clinical operations experience within the pharmaceutical or biotechnology industry.

Significant experience leading global late-phase (Phase 3) studies.

Demonstrated success in direct people management including hiring performance management and team development.

Proven ability to lead complex cross-functional teams and influence at senior leadership levels.

Strong expertise in CRO oversight global regulatory environments and inspection readiness.

Strategic thinker with strong operational execution skills.

Deep working knowledge of ICH/GCP and global clinical development regulations.

Education

Bachelors degree required; advanced degree (MS MPH PharmD PhD) strongly preferred.

Nice to Have

Late-phase respiratory or immunology therapeutic area experience.

Experience building or scaling clinical development functions in a high-growth organization.

Who Will Love This Job:

Generate:Biomedicines is pioneering Generative Biology to design and develop novel therapeutics with unprecedented precision. As a Director you will play a critical role not only in delivering a high-impact late-stage asthma program but also in shaping how we build and scale our clinical development organization.

Youll join a collaborative curious patient-first team where scientific creativity and operational excellence come together to advance programs with the potential for large-scale impact.

Generate:Biomedicines is committed to equal employment opportunity regardless of race color ancestry religion sex national origin sexual orientation age citizenship marital status disability gender identity or Veteran status.

Recruitment & Staffing Agencies: Generate:Biomedicines does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Generate:Biomedicines or its employees is strictly prohibited unless contacted directly by the Companys internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Generate:Biomedicines and the Company will not owe any referral or other fees with respect thereto.

#LI-RT1